| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.022 | 0.9 |